PLA2G3
protein-codingphospholipase A2 group III, the group of Phospholipases
Gene summary
This gene encodes a protein that belongs to the secreted phospholipase A2 family, whose members include the bee venom enzyme. The encoded enzyme functions in lipid metabolism and catalyzes the calcium-dependent hydrolysis of the sn-2 acyl bond of phospholipids to release arachidonic acid and lysophospholipids. This enzyme acts as a negative regulator of ciliogenesis, and may play a role in cancer development by stimulating tumor cell growth and angiogenesis. This gene is associated with oxidative stress, and polymorphisms in this gene are linked to risk for Alzheimer's disease. [provided by RefSeq, Apr 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~5.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PLA2G3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015715.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 2 | |||
| missense | 78 | 13 | 91 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 81 | 14 | 0 | 95 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056530.2 | 7 | MANE Select | |
| Ensembl | ENSP00000215885.3 | 7 | MANE Select | |
| Ensembl | ENSP00000597665.1 | 6 | Standard | |
| Ensembl | ENSP00000597665.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Ether lipid metabolism - Homo sapiens (human)
- Glycerophospholipid metabolism - Homo sapiens (human)
- Fat digestion and absorption - Homo sapiens (human)
- Vascular smooth muscle contraction - Homo sapiens (human)
- alpha-Linolenic acid metabolism - Homo sapiens (human)
Biological Process
- acrosome assembly
- phospholipid metabolic process
- sperm axoneme assembly
- lipid catabolic process
- lipoxygenase pathway
Molecular Function
- phospholipase A2 activity
- metal ion binding
- calcium-dependent phospholipase A2 activity
- phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)
- phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)
Cellular Component
- extracellular region
- extracellular space
- centriole
- plasma membrane
- mast cell granule
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000215885
- Coding exons
- 7
- Length
- 5799
- Individuals with no LoFs
- 124208
- Homozygous LoFs
- 3
- Heterozygous LoFs
- 1537
- Defined
- 125748
- p
- 0.00614
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.0713 | 307 | 304 | 1.01 | 0.0000176 | 3258 |
| Missense (PolyPhen) | 64 | 74.826 | 0.85531 | 916 | ||
| Synonymous | -1.16 | 137 | 121 | 1.13 | 0.00000666 | 1041 |
| Loss of Function | 0.976 | 19 | 24.2 | 0.786 | 0.00000139 | 216 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0014 | 0.0014 | notable |
| Latino/Admixed American | 0.0086 | 0.0086 | notable |
| Ashkenazi Jewish | 0.027 | 0.027 | notable |
| East Asian | 0.00038 | 0.00038 | rare |
| Finnish | 0.0015 | 0.0015 | notable |
| European (Non-Finnish) | 0.0072 | 0.0071 | notable |
| South Asian | 0.0013 | 0.0013 | notable |
| Other | 0.010 | 0.010 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2- acyl groups in 3-sn-phosphoglycerides. Shows an 11-fold preference for phosphatidylglycerol over phosphatidylcholine (PC). Preferential cleavage: 1-palmitoyl-2-linoleoyl- phosphatidylethanolamine (PE) > 1-palmitoyl-2-linoleoyl-PC > 1- palmitoyl-2-arachidonoyl-PC > 1-palmitoyl-2-arachidonoyl-PE. Plays a role in ciliogenesis. {ECO:0000269|PubMed:12522102, ECO:0000269|PubMed:20393563}.;
Recessive Scores
- pRec
- 0.0982
Intolerance Scores
- LoFtool
- 0.915
- RVIS EVS
- 1.29
- RVIS percentile EVS
- 93.88
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0384
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | Medium | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |